"TBSF" Human Immunoglobulin for Intravenous Use

Negara: Australia

Bahasa: Inggris

Sumber: Department of Health (Therapeutic Goods Administration)

Bahan aktif:

normal immunoglobulin, Quantity: 60 g/L

Tersedia dari:

CSL Behring Australia Pty Ltd

INN (Nama Internasional):

normal immunoglobulin

Bentuk farmasi:

Injection, solution

Komposisi:

Excipient Ingredients: maltose

Rute administrasi :

Intravenous

Unit dalam paket:

50mL, 200mL

Kelas:

Medicine Listed (Export Only)

Jenis Resep:

(S1) This Schedule is intentionally blank

Indikasi Terapi:

TBSF Human Immunoglobulin for Intravenous Use is indicated for replacement IgG therapy in: * primary immunodeficiency (PID) * symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment. TBSF Human Immunoglobulin for Intravenous Use is indicated for immunomodulatory therapy in: * Idiopathic Thrombocytopenic Purpura (ITP), in adults or children at high risk of bleeding or prior to surgery to correct the platelet count * allogeneic bone marrow transplantation * Kawasaki disease * Guillain-Barre Syndrome (GBS).

Ringkasan produk:

Visual Identification: Clear, colourless solution; Container Type: Vial; Container Life Time: 3 Years; Container Temperature: Store at 2 to 8 degrees Celsius

Status otorisasi:

Listed (Export Only)

Tanggal Otorisasi:

2006-03-01